Back to BCRX
TWO SIGMA INVESTMENTS, LP → BCRX
TWO SIGMA INVESTMENTS, LP BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
14
Latest value
$67.8M
Q2 2026
Peak value
$67.8M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $11.2M |
| Q2 2023 | $9.4M |
| Q3 2023 | $12.4M |
| Q4 2023 | $14.1M |
| Q1 2024 | $8M |
| Q2 2024 | $10.3M |
| Q3 2024 | $13.4M |
| Q4 2024 | $13.3M |
| Q1 2025 | $15.3M |
| Q2 2025 | $38.4M |
| Q3 2025 | $33.5M |
| Q4 2025 | $35.2M |
| Q1 2026 | $60.9M |
| Q2 2026 | $67.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $67.8M | 6.78M | — | — |
| Q1 2026 | $60.9M | 6.39M | — | — |
| Q4 2025 | $35.2M | 4.52M | — | — |
| Q3 2025 | $33.5M | 4.42M | — | — |
| Q2 2025 | $38.4M | 4.29M | — | — |
| Q1 2025 | $15.3M | 2.05M | — | — |
| Q4 2024 | $13.3M | 1.77M | — | — |
| Q3 2024 | $13.4M | 1.76M | — | — |
| Q2 2024 | $10.3M | 1.67M | — | — |
| Q1 2024 | $8M | 1.57M | — | — |
| Q4 2023 | $14.1M | 2.35M | — | — |
| Q3 2023 | $12.4M | 1.76M | — | — |
| Q2 2023 | $9.4M | 1.33M | — | — |
| Q1 2023 | $11.2M | 1.34M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M